Recherche mobile Health
Qualité des données aux normes académiques
En collaboration avec des centres de recherche sur le cancer, des cliniques et le secteur des sciences de la vie, nous nous engageons pour la responsabilisation des patients (participation et codécision dans le domaine de la santé) et la collecte de données au niveau des études réglementaires. Les symptômes relevés par les patients, associés aux données cliniques, ouvrent ainsi de nouvelles connaissances et possibilités pour les soins médicaux et la recherche (en utilisant des données concrètes).
Plus de 1000 patients sont déjà connectés à notre système.
Cela permet de développer des nouvelles méthodes ciblées pour le traitement du cancer et des maladies.
En tant que patient
Vous soutenez la recherche sur le cancer en partageant vos données dans l’application de façon pseudonymisée. Vous contribuez ainsi à l’amélioration du traitement grâce à votre expérience de patient – volontairement, bien entendu.
En tant que médecin
Vous soutenez la recherche sur le cancer en aidant vos patients à utiliser l’application et en participant à des études de cybersanté et à des registres.
Co-création
Initier ensemble des nouvelles approches de recherche – Vous avez une idée ? Nous avons les outils, les contacts et l’expérience nécessaires.
Studies and Publications
- Proprietary Consilium Care Platform & App
CE-Mark Class I (MDD Class I)
Enables symptom progression tracking and CTCAE-based notifications to patients and oncologists.
- Clinical Trial: Patient-App Improves Daily Activity
Randomized trial in 140 breast cancer patients undergoing chemotherapy
📰 Published in JMIR 2016
- Collaboration with SAKK – Alpine Tumor Immunology Registry (TIR)
Symptom recording in 150 patients undergoing immunotherapy
✔️ Accepted for publication in Current Oncology
(Topic: machine learning on ePROs to cluster symptoms by cancer type)
- Consilium App Improves ePRO Monitoring in Immunotherapy
Case report in lung cancer: shared reporting improves comfort and efficiency
📰 Case Reports in Oncology, 2020
- Clinical Trial: Patient-App Improves Symptom Recording
Digital symptom recording enhances patient-doctor interaction in 192 cancer patients
📰 JMIR Cancer, 2021
- Report on Medication Effectiveness in Personalized Medicine
Durable response and tolerability in breast cancer therapy
📰 Case Reports in Oncology, 2021
- Review: ePROs Improve Congruence of Patient- and Clinician-Reported Toxicity
Collaborative monitoring in 224 cancer patients
📰 JMIR, 2021
- HER2-Biosimilar in Breast Cancer (OGIPRO Study)
Real-world ePRO observational trial – 80 patients, 8 centers
📰 Published in JMIR Cancer (2024)
🔗 Article
Ongoing Trials and Registries
- THC-CBD for Nausea, Emesis, Sleeplessness, Pain, Anxiety, Appetite Loss in Cancer Assessed via ePRO
Prospective randomized controlled study – 150 patients, 6 centers
Registry now maintained under Swiss sponsorship
- Efficiency of the “Medidux” Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU)
Observational study on emergency-related symptom tracking and cost reduction
🔗 ClinicalTrials.gov: NCT06655337
- Evaluation of the Positive Care Effect of the Digital Health App Consilium Care Oncology
Multicenter randomized controlled trial with 520 patients, 40 centers (Germany & Switzerland)
🧪 Ongoing trial
Ethics Approval: KEK-2022-D0021
Team and expertise
Products developed by qualified experts
Andreas holds a position as senior oncologist at both, the Brust- and the OnkoZentrum Zürich in Switzerland. Moreover, he is a titular-professor at the medical faculty of the University of Zurich. Treating cancer patients over more than 20 years clearly indicated that the consideration of PROs is key for treatment success. Driven by this conviction Andreas founded Mobile Health AG and started to develop Consilium Care™, an App for patients to capture well-being and therapy side effects. The current large observational study, started in 2018, investigates the efficiency of the “Consilium Care™” smartphone App for detecting symptoms and treatment side effects in cancer patients depending on form of medication application, age and outpatient characteristics.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Individual patient
- Better care through early detection of severe events (integrated alert-function)
- Gives structure, assurance
- Self-empowerment
- Easy & fast communication with doctor
Doctor
- Standardized data boosts efficiency
- Enables physicians to focus on treatment
- Current data allows for better diagnoses
- Better retention through higher client satisfaction
- Track what is most effective over time
Consilium Care™ platform
- Synchronization & staorage / database
- Analytics & research
- Optimized quality / decision support
1. Patients track their health with Consilium Care™
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
3. Treatment plans can be adjusted due to insights
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Mobile Health
Evidence-based care in the real-world
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Navigation
Informations légales
